MiR-22 and Its Role in Colon Cancer
Author Information
Author(s): Yamakuchi Munekazu, Yagi Shusuke, Ito Takashi, Lowenstein Charles J.
Primary Institution: University of Rochester School of Medicine and Dentistry
Hypothesis
A set of microRNA regulate tumor responses to hypoxia by inhibiting components of the hypoxia signaling pathway.
Conclusion
MiR-22 may have an anti-angiogenic effect in colon cancer by inhibiting HIF-1α and VEGF expression.
Supporting Evidence
- MiR-22 expression is lower in colon cancer specimens compared to normal tissues.
- Over-expression of miR-22 inhibits HIF-1α expression.
- Knockdown of miR-22 enhances hypoxia-induced expression of HIF-1α and VEGF.
- Conditioned media from cells over-expressing miR-22 induce less endothelial cell growth and invasion.
Takeaway
MiR-22 is a tiny molecule that helps control how cancer cells respond to low oxygen levels, and it can stop the growth of blood vessels that feed tumors.
Methodology
The study involved measuring miR-22 expression in colon cancer and normal tissues, transfecting colon cancer cells with miR-22, and analyzing the effects on HIF-1α and VEGF expression.
Potential Biases
Potential bias in sample selection and the reliance on specific cell lines for experimental validation.
Limitations
The study was limited to specific cell lines and human specimens, which may not represent all colon cancer types.
Participant Demographics
Human colon cancer specimens from patients at The Johns Hopkins Hospital.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website